{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T06:58:16Z","timestamp":1771484296585,"version":"3.50.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2009,2,12]],"date-time":"2009-02-12T00:00:00Z","timestamp":1234396800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"published-print":{"date-parts":[[2009,9]]},"DOI":"10.1007\/s00432-009-0557-9","type":"journal-article","created":{"date-parts":[[2009,2,11]],"date-time":"2009-02-11T16:37:30Z","timestamp":1234370250000},"page":"1169-1175","source":"Crossref","is-referenced-by-count":14,"title":["Predictive value of telomerase reverse transcriptase expression in patients with high risk superficial bladder cancer treated with adjuvant BCG immunotherapy"],"prefix":"10.1007","volume":"135","author":[{"given":"Ioannis","family":"Zachos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Panagiotis A.","family":"Konstantinopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerasimos P.","family":"Vandoros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michalis V.","family":"Karamouzis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Athanasios G.","family":"Papatsoris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Podimatas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonios","family":"Papachristodoulou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Chrisofos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charalambos","family":"Deliveliotis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Athanasios G.","family":"Papavassiliou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,2,12]]},"reference":[{"key":"557_CR1","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/350569a0","volume":"350","author":"EH Blackburn","year":"1991","unstructured":"Blackburn EH (1991) Structure and function of telomeres. Nature 350:569\u2013573. doi: 10.1038\/350569a0","journal-title":"Nature"},{"key":"557_CR2","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.ygyno.2005.04.035","volume":"98","author":"H Brustmann","year":"2005","unstructured":"Brustmann H (2005) Immunohistochemical detection of human telomerase reverse transcriptase (hTERT) and c-kit in serous ovarian carcinoma: a clinicopathologic study. Gynecol Oncol 98:396\u2013402. doi: 10.1016\/j.ygyno.2005.04.035","journal-title":"Gynecol Oncol"},{"key":"557_CR3","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.canlet.2005.09.005","volume":"240","author":"KY Chen","year":"2006","unstructured":"Chen KY, Lee LN, Yu CJ et al (2006) Elevation of telomerase activity positively correlates to poor prognosis of patients with non-small cell lung cancer. Cancer Lett 240:148\u2013156. doi: 10.1016\/j.canlet.2005.09.005","journal-title":"Cancer Lett"},{"key":"557_CR4","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1158\/0008-5472.CAN-04-3678","volume":"65","author":"P Dalerba","year":"2005","unstructured":"Dalerba P, Guiducci C, Poliani PL et al (2005) Reconstitution of human telomerase reverse transcriptase expression rescues colorectal carcinoma cells from in vitro senescence: evidence against immortality as a constitutive trait of tumor cells. Cancer Res 65:2321\u20132329. doi: 10.1158\/0008-5472.CAN-04-3678","journal-title":"Cancer Res"},{"key":"557_CR5","doi-asserted-by":"crossref","first-page":"3086","DOI":"10.1200\/JCO.2005.06.944","volume":"23","author":"J Domont","year":"2005","unstructured":"Domont J, Pawlik TM, Boige V et al (2005) Catalytic subunit of human telomerase reverse transcriptase is an independent predictor of survival in patients undergoing curative resection of hepatic colorectal metastases: a multicenter analysis. J Clin Oncol 23:3086\u20133093. doi: 10.1200\/JCO.2005.06.944","journal-title":"J Clin Oncol"},{"key":"557_CR6","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1093\/annonc\/mdi408","volume":"16","author":"T Dutu","year":"2005","unstructured":"Dutu T, Michiels S, Fouret P et al (2005) Differential expression of biomarkers in lung adenocarcinoma: a comparative study between smokers and never-smokers. Ann Oncol 16:1906\u20131914. doi: 10.1093\/annonc\/mdi408","journal-title":"Ann Oncol"},{"key":"557_CR7","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1477-3163-4-17","volume":"4","author":"AE Elkak","year":"2005","unstructured":"Elkak AE, Meligonis G, Salhab M et al (2005) hTERT protein expression is independent of clinicopathological parameters and c-Myc protein expression in human breast cancer. J Carcinog 4:17. doi: 10.1186\/1477-3163-4-17","journal-title":"J Carcinog"},{"key":"557_CR8","doi-asserted-by":"crossref","first-page":"24764","DOI":"10.1074\/jbc.M201227200","volume":"277","author":"KT Etheridge","year":"2002","unstructured":"Etheridge KT, Banik SS, Armbruster BN et al (2002) The nucleolar localization domain of the catalytic subunit of human telomerase. J Biol Chem 277:24764\u201324770. doi: 10.1074\/jbc.M201227200","journal-title":"J Biol Chem"},{"key":"557_CR9","first-page":"3750","volume":"63","author":"ML Falchetti","year":"2003","unstructured":"Falchetti ML, Pierconti F, Casalbore P et al (2003) Glioblastoma induces vascular endothelial cells to express telomerase in vitro. Cancer Res 63:3750\u20133754","journal-title":"Cancer Res"},{"key":"557_CR10","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1046\/j.1442-2042.2000.00130.x","volume":"7","author":"T Fujioka","year":"2000","unstructured":"Fujioka T, Hasegawa M, Suzuki Y et al (2000) Telomerase activity in human renal cell carcinoma. Int J Urol 7:16\u201321. doi: 10.1046\/j.1442-2042.2000.00130.x","journal-title":"Int J Urol"},{"key":"557_CR11","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/S0022-5347(05)65756-4","volume":"166","author":"HW Herr","year":"2001","unstructured":"Herr HW, Sogani PC (2001) Does early cystectomy improve the survival of patients with high risk superficial bladder tumors? J Urol 166:1296\u20131299. doi: 10.1016\/S0022-5347(05)65756-4","journal-title":"J Urol"},{"key":"557_CR12","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S0022-5347(17)40575-1","volume":"141","author":"HW Herr","year":"1989","unstructured":"Herr HW, Badalament RA, Amato DA et al (1989) Superficial bladder cancer treated with Bacillus Calmette-Guerin: a multivariate analysis of factors affecting tumor progression. J Urol 141:22\u201329","journal-title":"J Urol"},{"key":"557_CR13","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1200\/JCO.1995.13.6.1404","volume":"13","author":"HW Herr","year":"1995","unstructured":"Herr HW, Schwalb DM, Zhang ZF et al (1995) Intravesical Bacillus Calmette-Guerin therapy prevents tumor progression and death from superficial bladder cancer: ten-year follow-up of a prospective randomized trial. J Clin Oncol 13:1404\u20131408","journal-title":"J Clin Oncol"},{"key":"557_CR14","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.urology.2005.07.062","volume":"66","author":"Z Kirkali","year":"2005","unstructured":"Kirkali Z, Chan T, Manoharan M et al (2005) Bladder cancer: epidemiology, staging and grading, and diagnosis. Urology 66:4\u201334. doi: 10.1016\/j.urology.2005.07.062","journal-title":"Urology"},{"key":"557_CR15","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/S0002-9610(01)00566-9","volume":"181","author":"T Kobayashi","year":"2001","unstructured":"Kobayashi T, Kubota K, Takayama T et al (2001) Telomerase activity as a predictive marker for recurrence of hepatocellular carcinoma after hepatectomy. Am J Surg 181:284\u2013288. doi: 10.1016\/S0002-9610(01)00566-9","journal-title":"Am J Surg"},{"key":"557_CR16","first-page":"3794","volume":"9","author":"K Kraemer","year":"2003","unstructured":"Kraemer K, Fuessel S, Schmidt U et al (2003) Antisense-mediated hTERT inhibition specifically reduces the growth of human bladder cancer cells. Clin Cancer Res 9:3794\u20133800","journal-title":"Clin Cancer Res"},{"key":"557_CR17","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/S0022-5347(17)38439-2","volume":"145","author":"DL Lamm","year":"1991","unstructured":"Lamm DL, DeHaven JI, Shriver J et al (1991) Prospective randomized comparison of intravesical with percutaneous Bacillus Calmette-Guerin versus intravesical Bacillus Calmette-Guerin in superficial bladder cancer. J Urol 145:738\u2013740","journal-title":"J Urol"},{"key":"557_CR18","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1038\/sj.bjc.6601643","volume":"90","author":"S Lantuejoul","year":"2004","unstructured":"Lantuejoul S, Soria JC, Moro-Sibilot D et al (2004) Differential expression of telomerase reverse transcriptase (hTERT) in lung tumours. Br J Cancer 90:1222\u20131229. doi: 10.1038\/sj.bjc.6601643","journal-title":"Br J Cancer"},{"key":"557_CR19","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1158\/1078-0432.CCR-04-1376","volume":"11","author":"S Lantuejoul","year":"2005","unstructured":"Lantuejoul S, Soria JC, Morat L et al (2005) Telomere shortening and telomerase reverse transcriptase expression in preinvasive bronchial lesions. Clin Cancer Res 11:2074\u20132082. doi: 10.1158\/1078-0432.CCR-04-1376","journal-title":"Clin Cancer Res"},{"key":"557_CR20","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/j.urology.2007.02.064","volume":"69","author":"CT Lee","year":"2007","unstructured":"Lee CT, Dunn RL, Ingold C et al (2007) Early-stage bladder cancer surveillance does not improve survival if high-risk patients are permitted to progress to muscle invasion. Urology 69:1068\u20131072. doi: 10.1016\/j.urology.2007.02.064","journal-title":"Urology"},{"key":"557_CR21","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1084\/jem.20040178","volume":"199","author":"JR Reed","year":"2004","unstructured":"Reed JR, Vukmanovic-Stejic M, Fletcher JM et al (2004) Telomere erosion in memory T cells induced by telomerase inhibition at the site of antigenic challenge in vivo. J Exp Med 199:1433\u20131443. doi: 10.1084\/jem.20040178","journal-title":"J Exp Med"},{"key":"557_CR22","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0302-2838(03)00048-4","volume":"43","author":"F Saint","year":"2003","unstructured":"Saint F, Salomon L, Quintela R et al (2003) Do prognostic parameters of remission versus relapse after Bacillus Calmette-Guerin (BCG) immunotherapy exist? Analysis of a quarter century of literature. Eur Urol 43:351\u2013360. doi: 10.1016\/S0302-2838(03)00048-4 (discussion 360\u2013361)","journal-title":"Eur Urol"},{"key":"557_CR23","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s101470200024","volume":"7","author":"H Saitoh","year":"2002","unstructured":"Saitoh H, Mori K, Kudoh S et al (2002) BCG effects on telomerase activity in bladder cancer cell lines. Int J Clin Oncol 7:165\u2013170. doi: 10.1007\/s101470200024","journal-title":"Int J Clin Oncol"},{"key":"557_CR24","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0168-9525(96)30018-8","volume":"12","author":"JW Shay","year":"1996","unstructured":"Shay JW, Wright WE (1996) The reactivation of telomerase activity in cancer progression. Trends Genet 12:129\u2013131. doi: 10.1016\/0168-9525(96)30018-8","journal-title":"Trends Genet"},{"key":"557_CR25","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1464-410X.1990.tb14861.x","volume":"66","author":"T Shinka","year":"1990","unstructured":"Shinka T, Hirano A, Uekado Y et al (1990) Clinical study of prognostic factors of superficial bladder cancer treated with intravesical Bacillus Calmette-Guerin. Br J Urol 66:35\u201339. doi: 10.1111\/j.1464-410X.1990.tb14861.x","journal-title":"Br J Urol"},{"key":"557_CR26","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/BF02524345","volume":"11","author":"DL Smith","year":"2004","unstructured":"Smith DL, Soria JC, Morat L et al (2004) Human telomerase reverse transcriptase (hTERT) and Ki-67 are better predictors of survival than established clinical indicators in patients undergoing curative hepatic resection for colorectal metastases. Ann Surg Oncol 11:45\u201351. doi: 10.1007\/BF02524345","journal-title":"Ann Surg Oncol"},{"key":"557_CR27","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1097\/00042737-200108000-00005","volume":"13","author":"B Usselmann","year":"2001","unstructured":"Usselmann B, Newbold M, Morris AG et al (2001) Telomerase activity and patient survival after surgery for gastric and oesophageal cancer. Eur J Gastroenterol Hepatol 13:903\u2013908. doi: 10.1097\/00042737-200108000-00005","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"557_CR28","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1038\/sj.bjc.6602592","volume":"92","author":"O Uziel","year":"2005","unstructured":"Uziel O, Fenig E, Nordenberg J et al (2005) Imatinib mesylate (Gleevec) downregulates telomerase activity and inhibits proliferation in telomerase-expressing cell lines. Br J Cancer 92:1881\u20131891. doi: 10.1038\/sj.bjc.6602592","journal-title":"Br J Cancer"},{"key":"557_CR29","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1016\/S0022-5347(05)67022-X","volume":"164","author":"A Meijden Van Der","year":"2000","unstructured":"Van Der Meijden A, Sylvester R, Collette L et al (2000) The role and impact of pathology review on stage and grade assessment of stages Ta and T1 bladder tumors: a combined analysis of 5 European Organization for Research and Treatment of Cancer Trials. J Urol 164:1533\u20131537. doi: 10.1016\/S0022-5347(05)67022-X","journal-title":"J Urol"},{"key":"557_CR30","doi-asserted-by":"crossref","first-page":"2797","DOI":"10.1242\/jcs.03001","volume":"119","author":"YL Wu","year":"2006","unstructured":"Wu YL, Dudognon C, Nguyen E et al (2006) Immunodetection of human telomerase reverse-transcriptase (hTERT) re-appraised: nucleolin and telomerase cross paths. J Cell Sci 119:2797\u20132806. doi: 10.1242\/jcs.03001","journal-title":"J Cell Sci"},{"key":"557_CR31","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1006\/excr.2002.5541","volume":"277","author":"Y Yang","year":"2002","unstructured":"Yang Y, Chen Y, Zhang C et al (2002) Nucleolar localization of hTERT protein is associated with telomerase function. Exp Cell Res 277:201\u2013209. doi: 10.1006\/excr.2002.5541","journal-title":"Exp Cell Res"},{"key":"557_CR32","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/S0022-5347(01)61770-1","volume":"161","author":"AR Zlotta","year":"1999","unstructured":"Zlotta AR, Noel JC, Fayt I et al (1999) Correlation and prognostic significance of p53, p21WAF1\/CIP1 and Ki-67 expression in patients with superficial bladder tumors treated with Bacillus Calmette-Guerin intravesical therapy. J Urol 161:792\u2013798. doi: 10.1016\/S0022-5347(01)61770-1","journal-title":"J Urol"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-009-0557-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00432-009-0557-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-009-0557-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T22:39:51Z","timestamp":1559083191000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00432-009-0557-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,2,12]]},"references-count":32,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2009,9]]}},"alternative-id":["557"],"URL":"https:\/\/doi.org\/10.1007\/s00432-009-0557-9","relation":{},"ISSN":["0171-5216","1432-1335"],"issn-type":[{"value":"0171-5216","type":"print"},{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,2,12]]}}}